Olivier Hermine - Curriculum Vitae#

CURRENT POSITION

• 2013 Founder and Director of the Laboratory of Cellular and Molecular Basis of Hematological disorders and Therapeutic Implications – Imagine Institute for genetic diseases, INSERM U1163 and CNRS ERL 8254 (Paris, France): https://www.institutimagine.org/en/research/25-research-labs/120-laboratory-of-molecular-mechanisms-of-hematologic-disorders-and-therapeutic-implications.html
  
• 2012 Founder and coordinator of Laboratory of Excellence “The Red Blood Cell” (Labex GR-Ex), selected and funded by the French Major Investments for the Future program (Paris, France). http://www.labex-grex.com
  
• 2009 Head of the Hematology Department of Necker Hospital (Paris, France)
  
• 2008 Founder and coordinator of the National Reference Centre of Mastocytosis (CEREMAST), Necker Hospital (Paris, France)
  
• 1999 Professor of Hematology at Paris Descartes University (Paris, France)
  

SUPERVISION OF GRADUATE STUDENTS AND POSTDOCTORAL FELLOWS

Supervision of 8 Postdocs Director of 25 PhDs

TEACHING ACTIVITIES

• 2019 Medical and science program on Virus and oncognesis, Paris cité Medical school,
  
• 2016 Co-founder and director of the interdisciplinary Biotechnology Management Diploma (Masters): Paris Descartes University, Imagine Institute, Polytechnique and HEC Paris
  
• 2014 Lecturer at the French National Blood Transfusion Institute (INTS)
  
• 2008 Co-founder and coordinator of the Inter-University Diploma of Hematology in internal medicine (Paris, France)
  
• 2004 - 2019 Co-founder and coordinator of the Master of Onco-hematology of Paris-Sud University
  
• 1999 Lecturer in Basic and clinical Hematology, Paris Descartes University

INSTITUTIONAL RESPONSIBILITIES

• 2014 - 2018 Member and Head of the Scientific Committee of the French National Blood Transfusion Institute (INTS)
  
• 2010 Member of the Executive Committee of the Imagine Institute for genetic diseases
  

ENTREPRENARIAL ACTIVITIES

Co-founder and scientific director of AB science (kinase inhibitors in mast cell and basophil activation disorders) and of Inatherys (antibodies against transferrin receptor for immune disorders and cancer)

PUBLICATIONS

• 927 publications
  
• H Factor 137 indice i10 681 citations 73288
  
• https://pubmed.ncbi.nlm.nih.gov/?term=hermine+o&sort=date
  

PATENTS ( >25)